Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$13.17 - $16.4 $1.45 Million - $1.8 Million
-109,995 Closed
0 $0
Q3 2021

Nov 16, 2021

SELL
$16.3 - $17.26 $159,251 - $168,630
-9,770 Reduced 8.16%
109,995 $1.8 Million
Q2 2021

Aug 10, 2021

BUY
$16.55 - $18.64 $691,938 - $779,319
41,809 Added 53.63%
119,765 $2.02 Million
Q1 2021

May 13, 2021

BUY
$16.71 - $19.9 $1.3 Million - $1.55 Million
77,956 New
77,956 $1.43 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.